Preprint · CC-BY
via OpenAlex
Predicting Alzheimer’s Disease Phenotypes With Aging Clocks: An Exploratory Analysis
Cindy David Sarmento, Gabin Drouard, Toni Tapani Saari, Aino Aaltonen, Aino Heikkinen, Teemu Palviainen, Sanna‐Kaisa Herukka, Tarja Kokkola, Sari Kärkkäinen, FinnGen, Aarno V. Palotie, Valtteri Julkunen, Heiko Runz, Jaakko A. Kaprio, Miina Ollikainen
medRxiv · 2025
Abstract
Abstract Background The continuous aging of the world’s population urges the improvement of early diagnosis of age-related diseases, such as Alzheimer’s disease (AD). Blood proteomes can detect systemic and organ-specific disease-related changes and are accessible by minimally invasive blood draws. Methods We explored the potential of proteomic and epigenetic aging clocks as complementary biomarkers to established AD-related blood-based biomarkers (BBBs) and cognitive tests. Omics were generated from blood samples of 153 cognitively unimpaired individuals (average age 62 years). We investigated the associations of biological aging with BBBs and cognition, measured approximately nine years after the omics. We additionally tested whether dementia risk factors or genetic liability to them modulated these associations. Findings Accelerated systemic and brain-specific proteomic aging were linked with poorer cognitive functioning and higher plasma levels of neurofilament light chain. Interaction analysis showed that negative associations between proteomic aging and cognitive scores were stronger in individuals with lower genetic liability for type II diabetes. Altogether, proteomic clocks improved the explained variance in cognitive and biomarker measures by up to 18% compared with epigenetic clocks alone. Interpretation Our results support the potential of proteomes in detecting aging and AD-related phenotypes, particularly neurodegeneration and cognitive decline. However, co-morbidities may constitute confounding factors, highlighting the importance of further investigating proteomic aging in the context of AD using comprehensive approaches. Funding FIMM-EMBL International PhD Programme; Sigrid Jusélius Foundation; Academy of Finland; FinnGen.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2025.09.01.25334848
- Canonical
- link ↗
- Fetched
- 2026-11-04 MST
Cite this
APA
Sarmento, C.D., Drouard, G., Saari, T.T., Aaltonen, A., Heikkinen, A., Palviainen, T., Herukka, S., Kokkola, T., Kärkkäinen, S., FinnGen, Palotie, A.V., Julkunen, V., Runz, H., Kaprio, J.A., Ollikainen, M., & Vuoksimaa, E. (2025). Predicting Alzheimer’s Disease Phenotypes With Aging Clocks: An Exploratory Analysis. <em>medRxiv</em>. https://doi.org/10.1101/2025.09.01.25334848
Vancouver
Sarmento CD, Drouard G, Saari TT, Aaltonen A, Heikkinen A, Palviainen T, et al. Predicting Alzheimer’s Disease Phenotypes With Aging Clocks: An Exploratory Analysis. medRxiv. 2025. doi:10.1101/2025.09.01.25334848.
BibTeX
@unpublished{cindy2025Predic,
title = {Predicting Alzheimer’s Disease Phenotypes With Aging Clocks: An Exploratory Analysis},
author = {Cindy David Sarmento and Gabin Drouard and Toni Tapani Saari and Aino Aaltonen and Aino Heikkinen and Teemu Palviainen and Sanna‐Kaisa Herukka and Tarja Kokkola and Sari Kärkkäinen and FinnGen and Aarno V. Palotie and Valtteri Julkunen and Heiko Runz and Jaakko A. Kaprio and Miina Ollikainen and Eero Vuoksimaa},
journal = {medRxiv},
year = {2025},
doi = {10.1101/2025.09.01.25334848},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Alzheimer's & dementia (Amsterdam, Netherlands) 2026
Open access · OA
Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2026
Open access · CC-BY
Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis
medRxiv 2023
Preprint · CC-BY
Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations
medRxiv 2025
Preprint · CC-BY
Multi-organ MRI digitizes biological aging clocks across proteomics, metabolomics, and genetics
2026
Preprint
Epigenetic signatures of biological vulnerability and residual risk in heart failure
Cell Reports Methods 2026
Open access · CC-BY